Centessa Pharmaceuticals plc
(NASDAQ: CNTA)
|
8:00 PM UTC, 06/20/25 | |||
---|---|---|---|---|
Last: $12.43 | Change: -0.25 | %Change: -1.97% | Volume: 1,612,616 |
08:49 AM EST, 11/12/2024 (MT Newswires) -- Centessa Pharmaceuticals (CNTA) reported a Q3 loss Tuesday of $0.37 per diluted share, wider than a loss of $0.40 a year earlier.
Analysts polled by Capital IQ expected a loss of $0.41.
As of September 30, cash and cash equivalents were $518.4 million, which is expected to fund operations into mid-2027.
http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.